OBJECTIVE: Cerebral critical closing pressure (CrCP) is the arterial pressure (AP) below which small arterial cerebral vessels collapse. Our objective was to estimate cerebral CrCP in 12 severe TBI patients, relating transcranial Doppler flow velocity (FV) and AP data. METHODS: FV, intracranial pressure (ICP) and invasive AP were prospectively acquired at 50 Hz. CrCP was estimated using three methods (M): M(1): amplitude ratio of FV/AP first harmonics; M(2): AP axis intersection of the regression line between systolic and diastolic values of FV and AP; M(3): AP axis intersection of the regression line between decreasing AP and FV simultaneous values. RESULTS: There were 12 patients. Frequent negative CrCP values were found. Average M(1):-12 mmHg; M(2):-33 mmHg; M(3):-43 mmHg. Correlation between the three methods was significant (P < 0.01). M(1) showed the lowest range and more positive values. The better limits of agreement (Bland and Altman test) were between M(2) and M(3). CONCLUSIONS: The frequently found negative values do not allow us for the moment, to use any of these three methods for clinical guidance.
OBJECTIVE: Cerebral critical closing pressure (CrCP) is the arterial pressure (AP) below which small arterial cerebral vessels collapse. Our objective was to estimate cerebral CrCP in 12 severe TBIpatients, relating transcranial Doppler flow velocity (FV) and AP data. METHODS: FV, intracranial pressure (ICP) and invasive AP were prospectively acquired at 50 Hz. CrCP was estimated using three methods (M): M(1): amplitude ratio of FV/AP first harmonics; M(2): AP axis intersection of the regression line between systolic and diastolic values of FV and AP; M(3): AP axis intersection of the regression line between decreasing AP and FV simultaneous values. RESULTS: There were 12 patients. Frequent negative CrCP values were found. Average M(1):-12 mmHg; M(2):-33 mmHg; M(3):-43 mmHg. Correlation between the three methods was significant (P < 0.01). M(1) showed the lowest range and more positive values. The better limits of agreement (Bland and Altman test) were between M(2) and M(3). CONCLUSIONS: The frequently found negative values do not allow us for the moment, to use any of these three methods for clinical guidance.
Authors: Georgios V Varsos; Nicolás de Riva; Peter Smielewski; John D Pickard; Ken M Brady; Matthias Reinhard; Alberto Avolio; Marek Czosnyka Journal: Neurocrit Care Date: 2013-06 Impact factor: 3.210
Authors: Shraddha Mainali; Danilo Cardim; Aarti Sarwal; Lisa H Merck; Sharon D Yeatts; Marek Czosnyka; Lori Shutter Journal: Neurocrit Care Date: 2022-04-06 Impact factor: 3.532
Authors: C Puppo; J Camacho; G V Varsos; B Yelicich; H Gómez; L Moraes; A Biestro; M Czosnyka Journal: Neurocrit Care Date: 2016-12 Impact factor: 3.210
Authors: Georgios V Varsos; Karol P Budohoski; Angelos G Kolias; Xiuyun Liu; Peter Smielewski; Vassilis G Varsos; Peter J Hutchinson; John D Pickard; Marek Czosnyka Journal: Neurocrit Care Date: 2014-10 Impact factor: 3.210
Authors: Georgios V Varsos; Hugh Richards; Magdalena Kasprowicz; Karol P Budohoski; Ken M Brady; Matthias Reinhard; Alberto Avolio; Peter Smielewski; John D Pickard; Marek Czosnyka Journal: J Cereb Blood Flow Metab Date: 2012-11-14 Impact factor: 6.200
Authors: Georgios V Varsos; Karol P Budohoski; Marek Czosnyka; Angelos G Kolias; Nathalie Nasr; Joseph Donnelly; Xiuyun Liu; Dong-Joo Kim; Peter J Hutchinson; Peter J Kirkpatrick; Vassilis G Varsos; Peter Smielewski Journal: J Cereb Blood Flow Metab Date: 2014-12-03 Impact factor: 6.200
Authors: Georgios V Varsos; Hugh K Richards; Magdalena Kasprowicz; Matthias Reinhard; Peter Smielewski; Ken M Brady; John D Pickard; Marek Czosnyka Journal: Neurocrit Care Date: 2014-02 Impact factor: 3.210